Literature DB >> 28365373

Marijuana and acute health care contacts in Colorado.

George Sam Wang1, Katelyn Hall2, Daniel Vigil2, Shireen Banerji3, Andrew Monte4, Mike VanDyke2.   

Abstract

Over 22 million Americans are current users of marijuana; half of US states allow medical marijuana, and several allow recreational marijuana. The objective of this study was to evaluate the impact marijuana has on hospitalizations, emergency department (ED) visits, and regional poison center (RPC) calls in Colorado, a medical and recreational marijuana state. This is a retrospective review using Colorado Hospital Association hospitalizations and ED visits with marijuana-related billing codes, and RPC marijuana exposure calls. Legalization of marijuana in Colorado has been associated with an increase in hospitalizations, ED visits, and RPC calls linked with marijuana exposure. From 2000 to 2015, hospitalization rates with marijuana-related billing codes increased from 274 to 593 per 100,000 hospitalizations in 2015. Overall, the prevalence of mental illness among ED visits with marijuana-related codes was five-fold higher (5.07, 95% CI: 5.0, 5.1) than the prevalence of mental illness without marijuana-related codes. RPC calls remained constant from 2000 through 2009. However, in 2010, after local medical marijuana policy liberalization, the number of marijuana exposure calls significantly increased from 42 to 93; in 2014, after recreational legalization, calls significantly increased by 79.7%, from 123 to 221 (p<0.0001). The age group <17years old also had an increase in calls after 2014. As more states legalize marijuana, it is important to address public education and youth prevention, and understand the impact on mental health disorders. Improvements in data collection and surveillance methods are needed to more accurately evaluate the public health impact of marijuana legalization.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cannabis; Colorado; Emergency department; Emergency room; Hospitalizations; Legalization; Marijuana; Poison center

Mesh:

Year:  2017        PMID: 28365373      PMCID: PMC5623152          DOI: 10.1016/j.ypmed.2017.03.022

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  18 in total

1.  Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999-2010.

Authors:  Marcus A Bachhuber; Brendan Saloner; Chinazo O Cunningham; Colleen L Barry
Journal:  JAMA Intern Med       Date:  2014-10       Impact factor: 21.873

2.  A case series of marijuana exposures in pediatric patients less than 5 years of age.

Authors:  George Sam Wang; Sandeep K Narang; Kathryn Wells; Ryan Chuang
Journal:  Child Abuse Negl       Date:  2011-08-03

3.  How many diagnosis fields are needed to capture safety events in administrative data? Findings and recommendations from the WHO ICD-11 Topic Advisory Group on Quality and Safety.

Authors:  Saskia E Drösler; Patrick S Romano; Vijaya Sundararajan; Bernard Burnand; Cyrille Colin; Harold Pincus; William Ghali
Journal:  Int J Qual Health Care       Date:  2013-12-13       Impact factor: 2.038

4.  Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study.

Authors:  Marta Di Forti; Arianna Marconi; Elena Carra; Sara Fraietta; Antonella Trotta; Matteo Bonomo; Francesca Bianconi; Poonam Gardner-Sood; Jennifer O'Connor; Manuela Russo; Simona A Stilo; Tiago Reis Marques; Valeria Mondelli; Paola Dazzan; Carmine Pariante; Anthony S David; Fiona Gaughran; Zerrin Atakan; Conrad Iyegbe; John Powell; Craig Morgan; Michael Lynskey; Robin M Murray
Journal:  Lancet Psychiatry       Date:  2015-02-25       Impact factor: 27.083

5.  Association of State Recreational Marijuana Laws With Adolescent Marijuana Use.

Authors:  Magdalena Cerdá; Melanie Wall; Tianshu Feng; Katherine M Keyes; Aaron Sarvet; John Schulenberg; Patrick M O'Malley; Rosalie Liccardo Pacula; Sandro Galea; Deborah S Hasin
Journal:  JAMA Pediatr       Date:  2017-02-01       Impact factor: 16.193

6.  Cannabis use and mental health-related quality of life among individuals with depressive disorders.

Authors:  Itay Aspis; Daniel Feingold; Mark Weiser; Jurgen Rehm; Gal Shoval; Shaul Lev-Ran
Journal:  Psychiatry Res       Date:  2015-09-10       Impact factor: 3.222

7.  Drug overdose surveillance using hospital discharge data.

Authors:  Svetla Slavova; Terry L Bunn; Jeffery Talbert
Journal:  Public Health Rep       Date:  2014 Sep-Oct       Impact factor: 2.792

Review 8.  Cannabis and development of dual diagnoses: A literature review.

Authors:  Rebecca C Hanna; Jessica M Perez; Subroto Ghose
Journal:  Am J Drug Alcohol Abuse       Date:  2016-09-09       Impact factor: 3.829

9.  Marijuana Tourism and Emergency Department Visits in Colorado.

Authors:  Howard S Kim; Katelyn E Hall; Emma K Genco; Mike Van Dyke; Elizabeth Barker; Andrew A Monte
Journal:  N Engl J Med       Date:  2016-02-25       Impact factor: 91.245

10.  Epidemiology of DSM-5 Drug Use Disorder: Results From the National Epidemiologic Survey on Alcohol and Related Conditions-III.

Authors:  Bridget F Grant; Tulshi D Saha; W June Ruan; Risë B Goldstein; S Patricia Chou; Jeesun Jung; Haitao Zhang; Sharon M Smith; Roger P Pickering; Boji Huang; Deborah S Hasin
Journal:  JAMA Psychiatry       Date:  2016-01       Impact factor: 21.596

View more
  20 in total

1.  High-Frequency Medical Cannabis Use Is Associated With Worse Pain Among Individuals With Chronic Pain.

Authors:  Kevin F Boehnke; J Ryan Scott; Evangelos Litinas; Suzanne Sisley; David A Williams; Daniel J Clauw
Journal:  J Pain       Date:  2019-09-24       Impact factor: 5.820

2.  Assessing the public health impacts of legalizing recreational cannabis use: the US experience.

Authors:  Wayne Hall; Michael Lynskey
Journal:  World Psychiatry       Date:  2020-06       Impact factor: 49.548

3.  Editorial for the special issue on behavior change, health, and health disparities 2017.

Authors:  Stephen T Higgins
Journal:  Prev Med       Date:  2017-10-29       Impact factor: 4.018

4.  Acute Illness Associated With Cannabis Use, by Route of Exposure: An Observational Study.

Authors:  Andrew A Monte; Shelby K Shelton; Eleanor Mills; Jessica Saben; Andrew Hopkinson; Brandon Sonn; Michael Devivo; Tae Chang; Jacob Fox; Cody Brevik; Kayla Williamson; Diana Abbott
Journal:  Ann Intern Med       Date:  2019-03-26       Impact factor: 25.391

5.  Syndromic Surveillance of Emergency Department Visits for Acute Adverse Effects of Marijuana, Tri-County Health Department, Colorado, 2016-2017.

Authors:  Grace E Marx; Yushiuan Chen; Michele Askenazi; Bernadette A Albanese
Journal:  Public Health Rep       Date:  2019-02-05       Impact factor: 2.792

6.  The state of the evidence on the association between state cannabis laws and opioid-related outcomes: A review.

Authors:  Kayla N Tormohlen; Mark C Bicket; Sarah White; Colleen L Barry; Elizabeth A Stuart; Lainie Rutkow; Emma E McGinty
Journal:  Curr Addict Rep       Date:  2021-09-28

7.  Cannabis use and risks of respiratory and all-cause morbidity and mortality: a population-based, data-linkage, cohort study.

Authors:  Nicholas T Vozoris; Jingqin Zhu; Clodagh M Ryan; Chung-Wai Chow; Teresa To
Journal:  BMJ Open Respir Res       Date:  2022-05

8.  Mental Health-related Emergency Department Visits Associated With Cannabis in Colorado.

Authors:  Katelyn E Hall; Andrew A Monte; Tae Chang; Jacob Fox; Cody Brevik; Daniel I Vigil; Mike Van Dyke; Katherine A James
Journal:  Acad Emerg Med       Date:  2018-04-10       Impact factor: 3.451

9.  Comparison of hospital claims and poison center data to evaluate health impact of opioids, cannabis and synthetic cannabinoids.

Authors:  George Sam Wang; Christine Buttorff; Asa Wilks; Daniel Schwam; Gregory J Tung; Shireen Banerji; Richard C Dart; Rosalie Liccardo Pacula
Journal:  Am J Emerg Med       Date:  2022-01-11       Impact factor: 2.469

10.  Cannabis-related emergency department visits by youths and their outcomes in Ontario: a trend analysis.

Authors:  Melanie Bechard; Paula Cloutier; Isac Lima; Mina Salamatmanesh; Roger Zemek; Maala Bhatt; Sinthuja Suntharalingam; Paul Kurdyak; Melissa Baker; William Gardner
Journal:  CMAJ Open       Date:  2022-02-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.